Hospitalizations for fractures after renal transplantation in the United States.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 11557176)

Published in Ann Epidemiol on October 01, 2001

Authors

K C Abbott1, R J Oglesby, I O Hypolite, A D Kirk, C W Ko, P G Welch, L Y Agodoa, W E Duncan

Author Affiliations

1: Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307, USA. kevin.abbott@na.amedd.army.mil

Articles citing this

Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes. Kidney Int (2013) 1.48

Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int (2003) 1.19

Reduced fracture risk with early corticosteroid withdrawal after kidney transplant. Am J Transplant (2011) 0.94

Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton. J Am Soc Nephrol (2014) 0.93

Long-term follow-up of kidney transplant recipients: comparison of hospitalization rates to the general population. Transplant Res (2013) 0.90

Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities. Clin Exp Nephrol (2015) 0.85

Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc (2008) 0.82

Trabecular bone score in kidney transplant recipients. Osteoporos Int (2015) 0.82

Bone disease after renal transplantation. Nat Rev Nephrol (2009) 0.81

Paricalcitol for secondary hyperparathyroidism in renal transplantation. J Am Soc Nephrol (2014) 0.78

Spine Trabecular Bone Score as an Indicator of Bone Microarchitecture at the Peripheral Skeleton in Kidney Transplant Recipients. Clin J Am Soc Nephrol (2017) 0.78

Renale osteodystrophie. Wien Med Wochenschr (2013) 0.77

Comparison of single CT scan assessment of bone mineral density, vascular calcification and fat mass with standard clinical measurements in renal transplant subjects: the ABC HeART study. BMC Nephrol (2015) 0.75

Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis. Medicine (Baltimore) (2016) 0.75

Is total hip arthroplasty safely performed in lung transplant patients? Current experience from a retrospective study of the Zurich lung transplant cohort. Patient Saf Surg (2016) 0.75

Risk factors for fracture in adult kidney transplant recipients. World J Transplant (2016) 0.75

Frequency of bone mineral density testing in adult kidney transplant recipients from Ontario, Canada: a population-based cohort study. Can J Kidney Health Dis (2016) 0.75

Metabolic bone diseases in kidney transplant recipients. World J Nephrol (2012) 0.75

Can one evaluate bone disease in chronic kidney disease without a biopsy? Curr Opin Nephrol Hypertens (2014) 0.75

Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics. Curr Osteoporos Rep (2017) 0.75

Articles by these authors

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28

Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer (1999) 2.95

Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80

The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54

Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38

Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am J Transplant (2010) 2.37

Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98

Light-emitting carbazole derivatives: potential electroluminescent materials. J Am Chem Soc (2001) 1.91

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90

Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A (1999) 1.79

Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med (1994) 1.77

Factors associated with caregivers' choice of infant sleep position, 1994-1998: the National Infant Sleep Position Study. JAMA (2000) 1.76

Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67

Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation (2001) 1.62

Two-port needlescopic cholecystectomy: prospective study of 100 cases. Hong Kong Med J (2005) 1.60

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60

Life expectancy benefits of cancer screening in the end-stage renal disease population. Am J Kidney Dis (2000) 1.54

Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. Am J Transplant (2012) 1.54

Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. Am J Transplant (2011) 1.51

Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant (2014) 1.50

Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant (2010) 1.48

Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48

Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum (1998) 1.43

Two-port versus four-port laparoscopic cholecystectomy. Surg Endosc (2003) 1.43

Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42

Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41

A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant (2006) 1.40

The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant (2008) 1.39

In vitro dissolution of calcium carbonate preparations. Calcif Tissue Int (1991) 1.38

Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35

What's next in the pipeline. Am J Transplant (2008) 1.32

Two liters of polyethylene glycol-electrolyte lavage solution versus sodium phosphate as bowel cleansing regimen for colonoscopy: a prospective randomized controlled trial. Endoscopy (2002) 1.29

The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26

Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant (2011) 1.25

Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes (1999) 1.25

Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant (2011) 1.23

Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20

CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med (2000) 1.20

CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant (2011) 1.19

Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. Am J Transplant (2014) 1.19

CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am J Transplant (2011) 1.18

Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17

Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17

Miles to go…. Am J Transplant (2011) 1.17

Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg (2000) 1.16

Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16

Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant (2008) 1.15

Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells. Am J Transplant (2011) 1.15

Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant (2013) 1.14

Effect of electrical stimulation on acupuncture points in diabetic patients with gastric dysrhythmia: a pilot study. Digestion (2001) 1.13

Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11

Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation (2001) 1.11

Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 1.11

Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol (2001) 1.11

Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09

Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int (1997) 1.07

Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant (2011) 1.06

High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. Am J Transplant (2014) 1.05

The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation (1994) 1.04

Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy. Am J Transplant (2012) 1.04

Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol (1999) 1.02

Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Prostate Cancer Prostatic Dis (2002) 1.02

Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2001) 1.02

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation (2001) 1.01

Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01

Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis (1999) 1.01

Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus. Am J Transplant (2012) 1.01

Renal transplantation in end-stage sickle cell nephropathy. Transplantation (1999) 1.01

A novel monoclonal antibody to CD40 prolongs islet allograft survival. Am J Transplant (2012) 1.00

Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant (2005) 1.00

Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis (2001) 1.00

Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis (2001) 0.99

Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates. Am J Transplant (2011) 0.99

The utility of contrast-enhanced endoscopic ultrasound in monitoring ethanol-induced pancreatic tissue ablation: a pilot study in a porcine model. Endoscopy (2007) 0.98

Regulation of renal laminin in mice with type II diabetes. J Am Soc Nephrol (1999) 0.97

The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96

Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96

Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis (1999) 0.95

Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients. Am J Transplant (2008) 0.95

Successful treatment of persistent bacteremia after endoscopic injection of N-butyl-2-cyanoacrylate for gastric varices bleeding. Endoscopy (2007) 0.94

Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol (2001) 0.94

The United States Renal Data System's 1991 annual data report: an introduction. Am J Kidney Dis (1991) 0.94

A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis. Cancer Immunol Immunother (1997) 0.94

Human platelets activate porcine endothelial cells through a CD154-dependent pathway. Transplantation (2001) 0.93

Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol (1999) 0.93

Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int (2000) 0.92

Class II alloantibody and mortality in simultaneous liver-kidney transplantation. Am J Transplant (2013) 0.92

Autosomal dominant polycystic kidney disease: symptoms and clinical findings. Q J Med (1984) 0.92

Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol (2001) 0.92